These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18721216)

  • 21. Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans.
    Treesirichod A; Chaithirayanon S; Wongjitrat N
    Pediatr Dermatol; 2019 May; 36(3):330-334. PubMed ID: 30883877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for the use of topical corticosteroids in melasma.
    Menter A
    J Drugs Dermatol; 2004; 3(2):169-74. PubMed ID: 15098972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved quality of life with effective treatment of facial melasma: the pigment trial.
    Balkrishnan R; Kelly AP; McMichael A; Torok H
    J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: A single-blinded, randomized trial.
    Ghiasi M; Samii R; Tootoonchi N; Balighi K; Heidari S
    J Cosmet Dermatol; 2024 Jun; 23(6):2090-2096. PubMed ID: 38362706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the efficacy and safety profiles of 0.025% and 0.05% tretinoin creams in treating acanthosis nigricans: a randomized double-blinded study.
    Kritsanaviparkporn C; Treesirichod A
    Arch Dermatol Res; 2023 May; 315(4):963-970. PubMed ID: 36416980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
    Astaneh R; Farboud E; Nazemi MJ
    Int J Dermatol; 2005 Jul; 44(7):599-601. PubMed ID: 15985034
    [No Abstract]   [Full Text] [Related]  

  • 28. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma.
    Gano SE; Garcia RL
    Cutis; 1979 Feb; 23(2):239-41. PubMed ID: 421493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case series of acanthosis nigricans treated with topical trifarotene cream.
    Lee WG; Koh YG; Shin SH; Park KY; Lee HW
    J Cosmet Dermatol; 2023 Oct; 22(10):2862-2864. PubMed ID: 37060202
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
    Kang HY; Valerio L; Bahadoran P; Ortonne JP
    Am J Clin Dermatol; 2009; 10(4):251-60. PubMed ID: 19489658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acanthosis nigricans with tretinoin.
    Darmstadt GL; Yokel BK; Horn TD
    Arch Dermatol; 1991 Aug; 127(8):1139-40. PubMed ID: 1863071
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of acanthosis nigricans with oral isotretinoin.
    Katz RA
    Arch Dermatol; 1980 Jan; 116(1):110-1. PubMed ID: 7352756
    [No Abstract]   [Full Text] [Related]  

  • 34. [Familial acanthosis nigricans].
    Casado Jimenez M; Borbujo Martinez J; Jimenez Acosta F; Almagro Sanchez M; Soto Melo J
    Med Cutan Ibero Lat Am; 1988; 16(1):70-2. PubMed ID: 3287055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acanthosis nigricans and hypovitaminosis A. response to topical vitamin A acid.
    Montes LF; Hirschowitz BI; Krumdieck C
    J Cutan Pathol; 1974; 1(2):88-94. PubMed ID: 4220057
    [No Abstract]   [Full Text] [Related]  

  • 36. Microneedling with Drug Delivery (Hydroquinone 4% Serum) as an Adjuvant Therapy for Recalcitrant Melasma.
    Ramírez-Oliveros JF; de Abreu L; Tamler C; Vilhena P; de Barros MH
    Skinmed; 2020; 18(1):38-40. PubMed ID: 32167455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nevoid acanthosis nigricans: Report of four cases localized to the umbilicus.
    Reyes-Meza SE; Guevara-Gutiérrez E; Villanueva-Quintero G; Hernández-Arana S; Tlacuilo-Parra A
    Indian J Dermatol Venereol Leprol; 2021; 87(5):660-665. PubMed ID: 32719198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperkeratosis of the nipple associated with acanthosis nigricans: treatment with topical calcipotriol.
    Lee HW; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):529-30. PubMed ID: 15761439
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy and safety of 20% urea cream and 10% urea cream in the treatment of acanthosis nigricans in adolescents, a randomized comparative double-blind study.
    Treesirichod A; Chuenboonngarm S; Kritsanaviparkporn C
    J Cosmet Dermatol; 2022 Jul; 21(7):2859-2864. PubMed ID: 34619001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acanthosis nigricans associated with primary hypogonadism: successful treatment with topical calcipotriol.
    Gregoriou S; Anyfandakis V; Kontoleon P; Christofidou E; Rigopoulos D; Kontochristopoulos G
    J Dermatolog Treat; 2008; 19(6):373-5. PubMed ID: 18608738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.